Voglibose is an alpha glucosidase inhibitor that exhibits anti melanogenic,taj pharmaceuticals, news

Page 1

Home » Chemical News » Competition in Global Voglibose Market to Grow in the Years to Come

Competition in Global Voglibose Market to Grow in the Years to Come Home

News

Market Reports

2 Jun, 2016 in Chemical News tagged Diabetes / Pharmaceuticals / Voglibose by Andrew

Custom Research

 

Search Report Search Cart Products… - $0.00

Login

Search About Us

Report Categories Voglibose is an alpha-glucosidase inhibitor that exhibits anti-diabetic, anti- hyperglycemic, antihyperlipidemic, anti-melanogenic, and cardioprotective benefits. It is used for lowering postprandial blood glucose levels in people with diabetes mellitus.

Coatings & Adhesives

The market of Voglibose is mainly distributed in Europe, Asia-Pacific etc, such as Japan, South Korea, Germany and China. The global market for Voglibose is expected to reach over $1.0 billion by 2021, at a CAGR of 5.7% from 2015 to 2021. The growth of the global market is driven by the rising income levels, the rising awareness regarding the medicinal benefits of Voglibose.

Organic Chemicals

Voglibose acts by inhibition of alpha-glucosidase, an enzyme involved in the breakdown of ingested disaccharides (eg sucrose, maltose) into monosaccharides (eg glucose, fructose) in the gut to facilitate their absorption. The drug is taken just before meals to prevent the postprandial hyperglycemia seen in diabetics. This type of agent can be considered a drug of first choice in overweight diabetic patients, because unlike the sulphonylureas they are not known to stimulate weight gain. Consumption of Voglibose grew dramatically during 2008-2013, mainly as the demand from Japan and China etc. Global market for Voglibose was faced strong competition from generics, retooled drugs, other diabetes drugs etc. As it approved in Japan, Korea, China, Asia Pacific dominated the global Voglibose market in terms of volume and revenue. This trend is estimated to continue throughout the forecast period. The Asia Pacific Voglibose market is closely followed by Europe.

Food & Feed Additives Oleochemicals Pesticides Pharmaceutical Ingredients Polyurethane Silicones Surfactants

Top Rated Products N-Iodosuccinimide China Market and Forecast Research $1,800.00

Growth in the diabetes drugs sectors in Asia Pacific and Europe regions is a key factor for the high demand for voglibose. The production of Voglibose is mainly distributed in Japan, India, China etc.

N-Iodosuccinimide

Key market participants include Takeda Pharmaceutical Company Limited, Taj Group, Kissei

Forecast Research

PDFmyURL - online url to pdf conversion

Global Market and


Pharmaceutical Co., Ltd, Jinan Jianfeng Chemical Co.Ltd., Zhejiang Zhenyuan Pharmaceutical Co., Ltd., Pharmaxyn Laboratories Ltd etc. It is sold under the trade name Basen, Volix, GLUBES etc. The major market players have invested large amounts in local and emerging countries to enter and enhance their market position and distribution network through capacity expansion, supply agreements and industry chain build.

$2,600.00

In 1994, Takeda Chemical Industries has launched its new orally-active antidiabetes product Basen (voglibose) in Japan, its first market. A similar product, Bayer’s Glucobay (acarbose) was approved by Japan’s central Pharmaceutical Affairs Bureau in September 1993.

$1,800.00

In the report, a detailed qualitative analysis of the factors responsible for driving and restraining growth of the global Voglibose market and future opportunities are provided. This study analyzes, estimates, and forecasts the global Voglibose market in terms of demand and production, based on volume (kilotons) and revenue (USD$ million) from 2010 to 2021. Companies Mentioned: Takeda Pharmaceutical Company Limited Taj Group Kissei Pharmaceutical Co., Ltd Jinan Jianfeng Chemical Co.Ltd. Zhejiang Zhenyuan Pharmaceutical Co., Ltd. Pharmaxyn Laboratories Ltd Zhejiang Hisoar Pharmaceutical Co., Ltd. Ranbaxy Laboratories Limited … The market segments: Voglibose Market – Application Analysis Pharmaceuticals Voglibose Market – Regional Analysis North America Europe Asia Pacific Rest of the World (RoW) Key Topics Covered: PDFmyURL - online url to pdf conversion

Dimethyl Maleate (DMM) China Market and Forecast Research

Dimethyl Maleate (DMM) Global Market and Forecast Research $2,600.00 Diethyl Succinate China Market and Forecast Research $1,800.00


1. 2. 3. 4. 5. 6. 7. 8. 9. 10.

Voglibose Market – Market Overview Voglibose Market – Production Analysis (kilotons) Voglibose Market – Geographic Analysis Voglibose Market – Strategic Analysis Voglibose Market – Dynamics & Market Forces Voglibose Market – By Application Voglibose Market – Price (USD/ton), Import & Export Voglibose Market – Market Landscape Voglibose Market – By End User Company Profiles

Source: Front Research Publish Date: Jan. 2016 For more detailed information to visit Front Research (www.frontresearch.com) Contract us: sales@frontresearch.com or visit “Voglibose Global Market and Forecast Research 2016” report and the “Voglibose, China Market and Forecast Research 2016.”

← Tebuconazole Market – Global Analysis, Size, Share, Growth, Trends and Forecast, 2010 – 2021 Growing at a CAGR 3.9% – Global Octamethylcyclotetrasiloxane (D4) Market →

· © 2017 FrontResearch · · Powered by  ·

PDFmyURL - online url to pdf conversion


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.